Navigating CLIA, CAP, TJC, and COLA: Common Deficiencies and How to Avoid Them

Dr. Alec Saitman will share his expertise in interpreting regulations in terms of the most common deficiencies and how to systematically address the biggest offenders.

This is the second webinar in the series, From CLIA to Competency: Raising the Standards of Excellence in Clinical Laboratory Practice.

Objectives

- Interpret deficiency citations in the context of regulatory requirements and laboratory operations

- Identify the most frequently cited deficiencies across CLIA, CAP, TJC, and COLA inspections.

- Interpret deficiency citations in the context of regulatory requirements and laboratory operations.

- Analyze the underlying causes of common compliance gaps and their impact on laboratory quality and patient safety.

- Develop sustainable strategies for documentation, training, and quality improvement to reduce vulnerability to citations.

‍

Dr. Alec Saitman, PhD, C(ASCP), DABCC (CC, TC)

Associate Professor and Director of Chemistry and Toxicology

Dr. Alec Saitman completed PhD training in total synthetic organic chemistry at the University of California, San Diego. He then went on to complete fellowship training in Clinical Chemistry and Toxicology in the Department of Pathology at the University of California, San Diego. He is board-certified by the American Board of Clinical Chemistry (ABCC) in Clinical Chemistry and Toxicological Chemistry.

Dr. Saitman is currently an Associate Professor of Pathology and Laboratory Medicine at Oregon Health and Sciences University (OHSU) and serves as the director of chemistry and toxicology. His research focuses on the development of small molecule quantitation assays using mass spectrometry. His areas of interest include laboratory stewardship and laboratory informatics. He is particularly interested in establishing efficient production workflows to meet the growing testing demands in his laboratory.

‍

‍